FindTrial
Sign In

Omics characteristics and its apllication in sleeping-disordered breathing and cardiovascular diseases

Omics characteristics and its apllication in sleeping-disordered breathing and cardiovascular diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011027
Enrollment
Unknown
Registered
2017-03-31
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep-disordered breathing

Interventions

1:no

Sponsors

Beijign Anzhen Hospital & Beijing Institute of Heart, Lung and Blood Vessels Diseases
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: AHI = 15/h diagnosed with Polysomnography or AHI = 5/h together with (1) somnolence, fatigue, insomnia; (2) sleep arousal; (3) the observed snoring or apnea observed by others; (4) diagnosed as hypertension, cognitive disorders, affective disorders, coronary heart disease, stroke, congestive heart failure, type 2 diabetes and atrial fibrillation

Exclusion criteria

Exclusion criteria: 1. Simple snoring; 2. Upper airway resistance syndrome; 3. Obesity hypoventilation syndrome; 4. Narcolepsy; 5. Restless legs syndrome and periodic leg movements during sleep.

Design outcomes

Primary

MeasureTime frame
mortality and morbidity;—

Countries

China

Contacts

Public ContactWei Yongxiang

Beijing Institute of Beijing Heart, Lung and Blood Vessel Diseaes

qinyanwen@126.com+86 010-64456205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026